Vortrag
Treatment effects of once-weekly dulaglutide versus insulin glargine in patients with different baseline glycemic patterns (based on high/low fasting or high/low postprandial glucose): A post hoc analysis of the AWARD-2 clinical trial
Speaker
Datum:
30.05.2019 ,
Zeit:
15:00
|
Thema: 02. Klinische Diabetologie Typ-2-Diabetes
Details